News & Updates
Filter by Specialty:
Drinking tea may help preserve bone mineral density during menopause
Women who began drinking tea before entering menopause seem to have better bone mineral density (BMD) than those who started drinking during and after menopause, a recent study has found.
Drinking tea may help preserve bone mineral density during menopause
18 Oct 2021
3-day remdesivir prevents hospitalization, death in COVID-19
A 3-day course of remdesivir may help stave off COVID-19–related hospitalization and death, according to results of the phase III PINETREE study.
3-day remdesivir prevents hospitalization, death in COVID-19
18 Oct 2021
Drug-delivery device implant works well for neovascular AMD
An ocular implant that continuously dispenses an antivascular endothelial growth factor (anti-VEGF) therapy into the vitreous performs well in the management of neovascular age-related macular degeneration, affording disease control and achieving vision and anatomical outcomes similar to that obtained with monthly intravitreal injections, as shown in the phase III ARCHWAY trial.
Drug-delivery device implant works well for neovascular AMD
18 Oct 2021
Warfarin plus aspirin tied to higher bleeding risk than monotherapy in AF patients
The combination of aspirin and warfarin therapy appears to increase the risk of bleeding, with little benefit in reducing stroke or cardiovascular events compared with warfarin alone in patients with atrial fibrillation (AF), reveals a study.
Warfarin plus aspirin tied to higher bleeding risk than monotherapy in AF patients
18 Oct 2021
Cold atmospheric plasma device eases severity of atopic dermatitis
Use of the cold atmospheric plasma (CAP) device, which generates free radicals through the ionization of air at room temperature, results in significantly improved mild and moderate atopic dermatitis (AD) with no serious safety concerns, a study has shown.
Cold atmospheric plasma device eases severity of atopic dermatitis
18 Oct 2021
Antiplatelet plus anticoagulant therapy linked to better outcomes in COVID-19
Hospitalized patients with COVID-19 who receive antiplatelet and anticoagulant drugs concurrently may fare better than those given only therapeutic anticoagulation, according to a study.
